How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors
Open accessThe DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
OBJECTIVES: The diagnostic criteria for irritable bowel syndrome (IBS) have recently been updated from Rome III to Rome IV. Whereas in Rome III a diagnosis of IBS entailed chronic abdominal pain or discomfort at least 3 days per month, in Rome IV the term discomfort has been removed and the frequency of abdominal pain increased to at least 1 day per week. We examined how this change in IBS criteria impacts on clinical characteristics and pathophysiological factors. METHODS: A total of 542 Swedish subjects with Rome III IBS completed a baseline questionnaire enquiring for the number of abdominal pain days in the last 10 days; this was subsequently used as a surrogate marker to identify Rome IV IBS, in that (a) those with 0 or 1 day of pain were classed as Rome IV-negative, and (b) those with ≥2 days of pain were classed as Rome IV-positive. Comparisons were made between Rome IV-positive and -negative IBS groups for demographics, IBS subtype, gastrointestinal and psychological symptoms, somatisation, fatigue, disease-specific quality of life, rectal sensitivity, and oro-anal transit time. RESULTS: Overall, 85% of Rome III IBS patients fulfilled the Rome IV criteria for IBS, but 15% did not. Rome IV-positive subjects were significantly more likely to be female, have poorer quality of life, greater pain severity, bloating, somatisation, fatigue, and rectal sensitivity than Rome IV-negative subjects. There were no differences in severity of anxiety or depression, IBS subtypes, bowel habit dissatisfaction, or oro-anal transit time. Finally, increasing number of pain days correlated positively with symptoms and visceral hypersensitivity. CONCLUSIONS: Most Rome III-positive IBS patients seeking healthcare fulfil the Rome IV IBS criteria. They constitute a more severe group than those who lose their IBS diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139 · cited 1×
“The H ospital A nxiety a nd D epression scale [21] is a mood scale measuring symptoms over the last week.”
BackgroundLongstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
The PHQ-15: Validity of a New Measure for Evaluating the Severity of Somatic Symptoms
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200203000-00008 · Cited by 3,298 · cited 1×
“The Patient Health Questionnaire (PHQ)-12 somatisation score [22] is a modified version of the widely used PHQ-15 somatisation questionnaire [23] that excludes the three GI symptoms (nausea, abdominal pain, and altered bowel habit), as these are likely to be directly related to functional GI…”
MethodStool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244 · cited 1×
“Subtyping according to the Rome III criteria was based on information from a 2-week stool diary using the Bristol Stool Form scale (BSF) [8, 18].”
MethodLacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155
FRANCIS, C. Y., MORRIS, J., & WHORWELL, P. J. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.142318000.x · Cited by 1,708 · cited 2×
“At baseline, Rome III IBS subjects completed the IBS Severity Scoring System (IBS-SSS) questionnaire [19], of which one question asks “please enter the number of days you get abdominal pain in the last 10 days.”
MethodMeasuring the Functional Impact of Fatigue: Initial Validation of the Fatigue Impact Scale
Fisk, J. D., Ritvo, P. G., Ross, L., Haase, D. A., Marrie, T. J., & Schlech, W. F. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.supplement_1.s79 · Cited by 1,541 · cited 1×
“The Fatigue Impact Scale [24] consists of a total of 40 questions enquiring for the impact of fatigue over the preceding month.”
BackgroundAGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384 · cited 1×
“Guidelines for the management of IBS recommend the use of symptom-based criteria to aid clinicians towards making a positive diagnosis of IBS without the need to perform extensive investigations [6, 7].”
BackgroundSelf-citationIrritable Bowel Syndrome: A Clinical Review
Chey, W. D., Kurlander, J., & Eswaran, S. (2015) · JAMA · doi:10.1001/jama.2015.0954 · Cited by 1,081 · cited 1×
“IntroductIon Irritable bowel syndrome (IBS) is a functional bowel disorder, as defined by no identifiable structural or biochemical abnormality to explain the symptoms on routine clinical tests [1].”
Background
Cited by
Sperber, A. D., Bangdiwala, S. I., Drossman, D. A., Ghoshal, U. C., Simren, M., Tack, J., Whitehead, W. E., Dumitrascu, D. L., Fang, X., Fukudo, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.04.014 · Cited by 2,263
Self-citationBritish Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324598 · Cited by 592
“23 24 Moving from Rome III to Rome IV IBS may therefore reduce the likelihood of novel pharmacological therapies demonstrating efficacy in future randomised controlled trials (RCTs), due to the spectrum of symptom severity, or may mean that trials need to be considerably larger, and therefore more…”
Self-citationPalsson, O. S., Whitehead, W., Törnblom, H., Sperber, A. D., & Simren, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.021 · Cited by 461
“quency threshold of abdominal pain required by the new criteria.(16,17) This indicates that the drop in prevalence rate seen in our population-based study from using the new version of the criteria is not likely to reduce IBS diagnoses much in specialty clinics.”
BackgroundSelf-citationIbrahim, A., Ali, R. A. R., Manaf, M. R. A., Ahmad, N., Tajurruddin, F. W., Qin, W. Z., Desa, S. H. M., & Ibrahim, N. M. (2020) · PLOS ONE · doi:10.1371/journal.pone.0244680 · Cited by 174
Simpson, C. A., Mu, A., Haslam, N., Schwartz, O. S., & Simmons, J. G. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.124 · Cited by 164
Metadata
- Authors
- Aziz, I., Törnblom, H., Palsson, O. S., Whitehead, W. E., & Simrén, M.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Venue
- American Journal of Gastroenterology
- Published
- 2018-07
- Volume
- 113
- Issue
- 7
- Pages
- 1017-1025
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2805219334
- Cited by
- 132
- References
- 35
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 20 · 2023: 16 · 2022: 18 · 2021: 29 · 2020: 16 · 2019: 10 · 2018: 5
- FWCI
- 14.49
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- The American Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
- Keywords
- irritable bowel syndrome, Rome III criteria, Rome IV criteria, diagnostic criteria revision, visceral hypersensitivity, rectal sensitivity, quality of life, somatization, fatigue, bloating, IBS subtypes, anxiety and depression
- MeSH terms
- Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Pain Measurement, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Sweden, Cohort Studies, Abdominal Pain, Outcome Assessment, Health Care, Irritable Bowel Syndrome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors. https://app.cochat.ai/papers/10.1038/s41395-018-0074-z
- The paper
- Aziz, I., Törnblom, H., Palsson, O. S., Whitehead, W. E., & Simrén, M. (2018). How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors. American Journal of Gastroenterology. https://doi.org/10.1038/s41395-018-0074-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.